Mersana Therapeutics, Inc. (MRSN) Earning

NASDAQ Currency in USD Disclaimer

$1.62

north_east $0.09 (5.88%)
Day's range
$1.47
Day's range
$1.64

Mersana Therapeutics, Inc. Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2024 2 -$0.27 -$0.05 -$0.18
Q2 2024 2 -$0.25 -$0.05 -$0.17
Q3 2024 3 -$0.26 -$0.05 -$0.17
Q4 2024 5 -$0.20 -$0.10 -$0.15
Q1 2025 2 -$0.23 -$0.14 -$0.19
Q2 2025 1 -$0.28 -$0.06 -$0.19
Q3 2025 1 -$0.28 -$0.06 -$0.18
Q4 2025 1 -$0.27 -$0.05 -$0.18
Q1 2026 1 -$0.28 -$0.06 -$0.18
Q2 2026 1 -$0.26 -$0.05 -$0.17
Q3 2026 1 -$0.26 -$0.05 -$0.17
Q4 2026 1 -$0.26 -$0.05 -$0.17

Mersana Therapeutics, Inc. Earnings Date And Information

Mersana Therapeutics, Inc. last posted its earnings results on Wednesday, November 13th, 2024. The company reported $-0.09 earnings per share for the quarter, topping analysts' consensus estimates of $-0.18 by $0.09. The company had revenue of 12.60 M for the quarter and had revenue of 36.86 M for the year. Mersana Therapeutics, Inc. has generated $-1 earnings per share over the last year ($-1.48 diluted earnings per share) and currently has a price-to-earnings ratio of -2.66. Mersana Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.

Mersana Therapeutics, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
11/13/2024 Q3 2024 -$0.18 -$0.09 0.09 $7.53 M $12.60 M
08/13/2024 Q2 2024 -$0.18 -$0.20 -0.02 $8.72 M $2.29 M
05/09/2024 Q1 2024 -$0.18 -$0.16 0.02 $9.25 M
02/28/2024 Q4 2023 -$0.20 -$0.16 0.04 $10.70 M
11/07/2023 Q3 2023 -$0.31 -$0.35 -0.04 $9.60 M $7.70 M
08/08/2023 Q2 2023 -$0.39 -$0.47 -0.08 $12.93 M $10.65 M
05/09/2023 Q1 2023 -$0.41 -$0.53 -0.12 $7.80 M
02/28/2023 Q4 2022 -$0.47 -$0.45 0.02 $14.69 M
11/07/2022 Q3 2022 -$0.09 -$0.61 -0.52 $56.78 M $5.57 M
08/08/2022 Q2 2022 -$0.50 -$0.55 -0.05 $2.20 M $4.28 M
05/09/2022 Q1 2022 -$0.31 -$0.60 -0.29 $2.04 M
02/28/2022 Q4 2021 -$0.67 -$0.68 -0.01 $11,000
11/09/2021 Q3 2021 -$0.58 -$0.63 -0.05 $120,500 $11,000
08/06/2021 Q2 2021 -$0.50 -$0.59 -0.09 $170,000 $11,000
05/10/2021 Q1 2021 -$0.39 -$0.50 -0.11 $11,000
02/26/2021 Q4 2020 -$0.33 -$0.42 -0.09 $11,000
11/09/2020 Q3 2020 -$0.31 -$0.33 -0.02 $439,200 $11,000
08/07/2020 Q2 2020 -$0.30 -$0.33 -0.03 $306,000 $796,000
05/08/2020 Q1 2020 -$0.38 -$0.35 0.03 $11,000
02/28/2020 Q4 2019 -$0.38 -$0.34 0.04 $42,000
 

Mersana Therapeutics, Inc. Earnings: FAQ's

When is Mersana Therapeutics, Inc.'s earnings date?

Mersana Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.

Did Mersana Therapeutics, Inc. beat their earnings estimates last quarter?

In the previous quarter, Mersana Therapeutics, Inc. (:MRSN) reported $-0.09 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.18 by $0.09.

How can I listen to Mersana Therapeutics, Inc.'s earnings conference call?

The conference call for Mersana Therapeutics, Inc.'s latest earnings report can be listened to online.

How can I read Mersana Therapeutics, Inc.'s conference call transcript?

The conference call transcript for Mersana Therapeutics, Inc.'s latest earnings report can be read online.

How much revenue does Mersana Therapeutics, Inc. generate each year?

Mersana Therapeutics, Inc. (:MRSN) has a recorded annual revenue of $36.86 M.

How much profit does Mersana Therapeutics, Inc. generate each year?

Mersana Therapeutics, Inc. (:MRSN) has a recorded net income of $36.86 M. Mersana Therapeutics, Inc. has generated $-1.48 earnings per share over the last four quarters.

What is Mersana Therapeutics, Inc.'s price-to-earnings ratio?

Mersana Therapeutics, Inc. (:MRSN) has a price-to-earnings ratio of -2.66 and price/earnings-to-growth ratio is -0.09.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED